Rhythm
RHY.AXRhythm Biosciences Limited Price (RHY.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
228,296,917
(3.0492)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Rhythm Biosciences LimitedCurrency: AUD
| YEAR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
0.00
+0% |
0.00
+0% |
1,027,617.00
+0% |
100,000.00
-90% |
1,108,507.00
+1,009% |
2,427,406.00
+119% |
3,095,842.00
+28% |
1,690,144.00
-45% |
|||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 0.00 | 31,535.00 | 65,365.00 | 141,287.00 | 146,648.00 | 101,480.00 | 189,377.00 | 3,047,516.00 | |||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
0.00
+0% |
-31,535.00
+0% |
962,252.00
-3,151% |
-41,287.00
-104% |
961,859.00
-2,430% |
2,325,926.00
+142% |
2,906,465.00
+25% |
-1,357,372.00
-147% |
|||||||||||
| Gross Profit Ratio | (0.00%) | (0.00%) | (0.94%) | (-0.41%) | (0.87%) | (0.96%) | (0.94%) | (-0.80%) | |||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 299,520.00 | 359,111.00 | 980,283.00 | 1,939,431.00 | 4,554,750.00 | 5,159,179.00 | 3,647,711.00 | 2,345,560.00 | |||||||||||
| General and Administrative | 422,004.00 | 1,125,674.00 | 2,277,296.00 | 1,997,336.00 | 2,965,505.00 | 5,333,294.00 | 7,330,176.00 | 1,218,452.00 | |||||||||||
| Selling, General & Admin... | 72,127.00 | 1,219,151.00 | 2,580,230.00 | 2,039,182.00 | 3,028,326.00 | 5,895,154.00 | 7,505,734.00 | 3,004,308.00 | |||||||||||
| Selling & Marketing Exp... | -349,877.00 | 93,477.00 | 302,934.00 | 41,846.00 | 62,821.00 | 561,860.00 | 175,558.00 | 115,498.00 | |||||||||||
| Depreciation and Amortiz... | 805,524.00 | 31,535.00 | 65,365.00 | 141,287.00 | 146,648.00 | 101,480.00 | 189,377.00 | 110,006.00 | |||||||||||
| Other Expenses | 0.00 | -189,322.00 | 154,330.00 | 182,841.00 | 150,371.00 | 191,559.00 | 3,095,842.00 | 0.00 | |||||||||||
| Total Operating Expenses | 72,127.00 | 1,628,634.00 | 3,714,843.00 | 4,161,454.00 | 7,733,447.00 | 11,245,892.00 | 11,541,669.00 | 5,349,868.00 | |||||||||||
| Cost and Exponses | 72,127.00 | 1,628,634.00 | 3,714,843.00 | 4,161,454.00 | 7,733,447.00 | 11,245,892.00 | 11,541,669.00 | 8,397,384.00 | |||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-72,130.00
+0% |
-1,628,634.00
+2,158% |
-3,714,843.00
+128% |
-4,015,188.00
+8% |
-6,611,752.00
+65% |
-11,245,892.00
+70% |
-11,541,669.00
+3% |
-6,707,240.00
-42% |
|||||||||||
| Operating Income Ratio | (0.00%) | (0.00%) | (-3.62%) | (-40.15%) | (-5.96%) | (-4.63%) | (-3.73%) | (-3.97%) | |||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 0.00 | 64,476.00 | 141,066.00 | 46,266.00 | 13,973.00 | 24,965.00 | 228,270.00 | 52,282.00 | |||||||||||
| Interest Expenses | 0.00 | 0.00 | 0.00 | 7,796.00 | 396.00 | 24,965.00 | 0.00 | 3,143.00 | |||||||||||
| Total Other Income/Exp... | -60,000.00 | -156,381.00 | 1,168,684.00 | -102,817.00 | -133,856.00 | 2,452,371.00 | 3,324,113.00 | -1,839,665.00 | |||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 733,397.00 | -1,597,099.00 | -2,608,275.00 | -3,873,901.00 | -6,465,104.00 | -11,104,447.00 | -11,108,722.00 | -6,795,894.00 | |||||||||||
| EBITDA ratio | (0.00%) | (0.00%) | (-3.55%) | (-38.74%) | (-5.83%) | (-4.59%) | (-3.67%) | (-4.02%) | |||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -72,127.00 | -1,753,480.00 | -2,546,159.00 | -4,022,984.00 | -6,612,148.00 | -8,793,521.00 | -8,217,557.00 | -8,546,905.00 | |||||||||||
| Income Before Tax Ratio | (0.00%) | (0.00%) | (-2.48%) | (-40.23%) | (-5.96%) | (-3.62%) | (-2.65%) | (-5.06%) | |||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | -805,524.00 | 124,846.00 | -1,168,684.00 | 107,796.00 | 1,108,903.00 | -2,477,336.00 | -228,270.00 | -1,690,144.00 | |||||||||||
| Net Income | |||||||||||||||||||
| Net Income | -72,127.00
+0% |
-1,753,480.00
+2,331% |
-1,377,475.00
-21% |
-4,130,780.00
+200% |
-7,721,051.00
+87% |
-6,316,185.00
-18% |
-8,217,557.00
+30% |
-6,856,761.00
-17% |
|||||||||||
| Net Income Ratio | (0.00%) | (0.00%) | (-1.34%) | (-41.31%) | (-6.97%) | (-2.60%) | (-2.65%) | (-4.06%) | |||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.00 | -0.02 | -0.01 | -0.04 | -0.04 | -0.03 | -0.04 | -0.03 | |||||||||||
| Diluted EPS | 0.00 | -0.02 | -0.01 | -0.04 | -0.04 | -0.03 | -0.04 | -0.03 | |||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 117,926,444.00 | 89,294,644.00 | 117,926,444.00 | 117,926,444.00 | 189,947,785.00 | 214,445,137.00 | 221,541,713.00 | 228,299,960.00 | |||||||||||
| Diluted Share Outstanding | 117,926,444.00 | 89,294,644.00 | 117,926,444.00 | 117,926,444.00 | 189,947,785.00 | 214,445,137.00 | 221,541,713.00 | 228,296,917.00 | |||||||||||